Company profile
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Acer Therapeutics Inc.
20 Nov 23
SC 13D/A
Acer Therapeutics Inc.
2 Dec 22
4
Acer Therapeutics Inc.
1 Dec 22
4
Acer Therapeutics Inc.
19 Jan 22
4
Acer Therapeutics Inc.
20 Jan 21
SC 13D/A
Acer Therapeutics Inc.
3 Aug 20
4
Acer Therapeutics Inc.
28 Jul 20
4
Acer Therapeutics Inc.
5 Feb 19
4
Acer Therapeutics Inc.
6 Oct 17
SC 13D
Acer Therapeutics Inc.
29 Sep 17
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Nov 23 | Schelling Chris | Common Stock, $0.0001 par value per share | Sale back to company | Dispose D | No | No | 0 | 2,712,529 | 0.00 | 0 |
29 Nov 22 | Schelling Chris | Common Stock | Buy | Acquire P | No | No | 1.22 | 819,672 | 1,000.00 k | 2,712,529 |